Broker Forecast - Peel Hunt issues a broker note on Shield Therapeutics Plc

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Peel Hunt today reaffirms its buy investment rating on Shield Therapeutics Plc (LON:STX) and raised its price target to 200p (from 88p).

Broker Forecasts data provided by www.sharesmagazine.co.uk